Warning : mysqli_connect(): (HY000/1045): Access denied for user 'root'@'localhost' (using password: YES) in /opt/lampp/htdocs/ProtPathDB/database/db_connect.php on line 2
Failed to connect to MySQL: Access denied for user 'root'@'localhost' (using password: YES)
ProtPathDB
Targetp
Signalp
Mitoprot
MitoProt II - v1.101
File : /home/rajan/sadaf/4480_mitoprot/test/NF0116100.fa
Sequence name : NF0116100
Sequence length : 896
VALUES OF COMPUTED PARAMETERS
Coef20 : 3.171
CoefTot : -0.637
ChDiff : -3
ZoneTo : 5
KR : 0
DE : 0
CleavSite : 0
HYDROPHOBIC SCALE USED
GES KD GVH1 ECS
H17 : 2.318 3.194 0.531 0.994
MesoH : 1.176 1.370 0.125 0.570
MuHd_075 : 12.726 8.009 2.322 2.510
MuHd_095 : 13.825 6.907 3.490 3.123
MuHd_100 : 20.416 9.155 4.217 3.703
MuHd_105 : 20.491 8.773 3.884 3.333
Hmax_075 : 8.050 1.633 -0.216 2.473
Hmax_095 : 6.200 2.100 -0.423 3.080
Hmax_100 : 8.900 3.000 0.212 3.300
Hmax_105 : 6.400 -0.000 -0.666 2.150
CLASS NOT-MITO MITO(/CHLORO)
DFM : 0.9962 0.0038
DFMC : 0.9969 0.0031
##### ProP v.1.0b ProPeptide Cleavage Site Prediction #####
##### Furin-type cleavage site prediction (Arginine/Lysine residues) #####
896 NF0116100
MTNPGDYYSFLLSSHYDTVEFSAGASSDGTGVAVMLELLENVVNTVDNVIKYPVIFFFGGGSEYNFEATKEFMKNHEWSK 80
KCLRFINMDSSGSGGKSMVFRVTDNSILNEYNDAPHPYISVIGEEVMKLKTNYDTDFTVFSDKTYRNQTNTLPKYYLKGY 160
DYGYFWDGYFYGTQYDTYDRISRGTLQHLGDNVLHQLMKVVTDDNIMSGTVTNDAESNYLADEVYFDVLGGFYVHFSFQL 240
SQAIQGIIVVVDVILPIVLIIVDHMISLRYHDTSSVYQLFKKSISGLQARLLLIFLYFCSYGLSLGFGILLAALTGSIVD 320
GINAMPWYRDPVLAVFLFSTPTLLGMFISQFGVHLIINAAISSCGCFKMYRISLKSKSELKRGENTAAQTLIYAADKERY 400
LALTLFWGLLTAVSLMTQLKSFYIVYFWSFCLSGMLVLLLVVDRVIMWSYMIIRNQTRAKALEAAGADMSEELTSAGDNV 480
DKRKKFLELRRAKKKDDELSKEDEKYLGKLAAKRNMRHEIAAKLKEFSIRDFFHAVHYHQLYWVIVMSIACWPPATVTID 560
ILDRMIHLIIPLMSRASYPVCGAMIGSVIGLLIYLLTISYMPIMHRAANWGKAMILTGIVIAIVGITAVSMSGFQKYSPR 640
KVRFTQVNKVGPLDKDEISTIPYPMAATSTAPLKFDQSSSLATFTMESFDGIGITGLLNRFKGNYGANGGFFREYCKDSK 720
CEFIIRRPGAESFKALEYHLHLNQLTIANYGTQTENDETIASFDLTLTLKEGITLADYTGSLSGDGTLQKFQLASSDPNY 800
NNVLFYVDDSKTSKTIHKFGAPHTTTTISASVRYKTASTTKPTLSFNVQLYDCDLNASEVVKKFNDLYVNGMYYVTPLGS 880
TSCKLVTEQSTINIQL 960
................................................................................ 80
................................................................................ 160
................................................................................ 240
................................................................................ 320
................................................................................ 400
................................................................................ 480
................................................................................ 560
................................................................................ 640
................................................................................ 720
................................................................................ 800
................................................................................ 880
................ 960
Propeptide cleavage sites predicted: Arg(R)/Lys(K): 0
Name Pos Context Score Pred
____________________________v_________________
NF0116100 51 TVDNVIK|YP 0.065 .
NF0116100 70 YNFEATK|EF 0.061 .
NF0116100 74 ATKEFMK|NH 0.064 .
NF0116100 80 KNHEWSK|KC 0.062 .
NF0116100 81 NHEWSKK|CL 0.117 .
NF0116100 84 WSKKCLR|FI 0.091 .
NF0116100 96 SSGSGGK|SM 0.067 .
NF0116100 101 GKSMVFR|VT 0.189 .
NF0116100 128 IGEEVMK|LK 0.061 .
NF0116100 130 EEVMKLK|TN 0.069 .
NF0116100 143 FTVFSDK|TY 0.064 .
NF0116100 146 FSDKTYR|NQ 0.078 .
NF0116100 154 QTNTLPK|YY 0.083 .
NF0116100 158 LPKYYLK|GY 0.076 .
NF0116100 180 QYDTYDR|IS 0.072 .
NF0116100 183 TYDRISR|GT 0.259 .
NF0116100 199 VLHQLMK|VV 0.078 .
NF0116100 269 DHMISLR|YH 0.094 .
NF0116100 281 SVYQLFK|KS 0.066 .
NF0116100 282 VYQLFKK|SI 0.191 .
NF0116100 290 ISGLQAR|LL 0.089 .
NF0116100 329 NAMPWYR|DP 0.087 .
NF0116100 368 SSCGCFK|MY 0.079 .
NF0116100 371 GCFKMYR|IS 0.080 .
NF0116100 375 MYRISLK|SK 0.100 .
NF0116100 377 RISLKSK|SE 0.088 .
NF0116100 381 KSKSELK|RG 0.058 .
NF0116100 382 SKSELKR|GE 0.280 .
NF0116100 397 LIYAADK|ER 0.062 .
NF0116100 399 YAADKER|YL 0.100 .
NF0116100 420 SLMTQLK|SF 0.095 .
NF0116100 444 LLLVVDR|VI 0.088 .
NF0116100 454 WSYMIIR|NQ 0.083 .
NF0116100 458 IIRNQTR|AK 0.084 .
NF0116100 460 RNQTRAK|AL 0.111 .
NF0116100 482 AGDNVDK|RK 0.055 .
NF0116100 483 GDNVDKR|KK 0.183 .
NF0116100 484 DNVDKRK|KF 0.082 .
NF0116100 485 NVDKRKK|FL 0.093 .
NF0116100 490 KKFLELR|RA 0.088 .
NF0116100 491 KFLELRR|AK 0.094 .
NF0116100 493 LELRRAK|KK 0.154 .
NF0116100 494 ELRRAKK|KD 0.213 .
NF0116100 495 LRRAKKK|DD 0.179 .
NF0116100 501 KDDELSK|ED 0.064 .
NF0116100 505 LSKEDEK|YL 0.068 .
NF0116100 509 DEKYLGK|LA 0.059 .
NF0116100 513 LGKLAAK|RN 0.064 .
NF0116100 514 GKLAAKR|NM 0.155 .
NF0116100 517 AAKRNMR|HE 0.212 .
NF0116100 523 RHEIAAK|LK 0.068 .
NF0116100 525 EIAAKLK|EF 0.069 .
NF0116100 530 LKEFSIR|DF 0.178 .
NF0116100 564 TIDILDR|MI 0.104 .
NF0116100 575 IIPLMSR|AS 0.081 .
NF0116100 606 YMPIMHR|AA 0.108 .
NF0116100 612 RAANWGK|AM 0.066 .
NF0116100 636 SMSGFQK|YS 0.078 .
NF0116100 640 FQKYSPR|KV 0.123 .
NF0116100 641 QKYSPRK|VR 0.081 .
NF0116100 643 YSPRKVR|FT 0.329 .
NF0116100 649 RFTQVNK|VG 0.052 .
NF0116100 655 KVGPLDK|DE 0.067 .
NF0116100 674 TSTAPLK|FD 0.064 .
NF0116100 700 ITGLLNR|FK 0.117 .
NF0116100 702 GLLNRFK|GN 0.077 .
NF0116100 713 ANGGFFR|EY 0.099 .
NF0116100 717 FFREYCK|DS 0.064 .
NF0116100 720 EYCKDSK|CE 0.059 .
NF0116100 726 KCEFIIR|RP 0.077 .
NF0116100 727 CEFIIRR|PG 0.112 .
NF0116100 734 PGAESFK|AL 0.077 .
NF0116100 770 DLTLTLK|EG 0.054 .
NF0116100 790 GDGTLQK|FQ 0.059 .
NF0116100 811 FYVDDSK|TS 0.058 .
NF0116100 814 DDSKTSK|TI 0.078 .
NF0116100 818 TSKTIHK|FG 0.077 .
NF0116100 833 TISASVR|YK 0.148 .
NF0116100 835 SASVRYK|TA 0.107 .
NF0116100 841 KTASTTK|PT 0.062 .
NF0116100 862 NASEVVK|KF 0.070 .
NF0116100 863 ASEVVKK|FN 0.149 .
NF0116100 884 LGSTSCK|LV 0.089 .
____________________________^_________________
Nucleotide sequence
Protein sequence
N_Linked Glycosylation
O_Linked Glycosylation
Phosphorylation